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Abstract
Purpose The Oxford Knee Score (OKS) is a validated
12-item measure of knee replacement outcomes. An algo-
rithm to estimate EQ-5D utilities from OKS would facili-
tate cost-utility analysis on studies analyses using OKS but
not generic health state preference measures. We estimate
mapping (or cross-walking) models that predict EQ-5D
utilities and/or responses based on OKS. We also compare
different model specifications and assess whether different
datasets yield different mapping algorithms.
Methods Models were estimated using data from the
Knee Arthroplasty Trial and the UK Patient Reported
Outcome Measures dataset, giving a combined estimation
dataset of 134,269 questionnaires from 81,213 knee
replacement patients and an internal validation dataset of
45,213 questionnaires from 27,397 patients. The best
model was externally validated on registry data (10,002
observations from 4,505 patients) from the South West
London Elective Orthopaedic Centre. Eight models of the
relationship between OKS and EQ-5D were evaluated,
including ordinary least squares, generalized linear models,
two-part models, three-part models and response mapping.
Results A multinomial response mapping model using
OKS responses to predict EQ-5D response levels had best
prediction accuracy, with two-part and three-part models
also performing well. In the external validation sample, this
model had a mean squared error of 0.033 and a mean
absolute error of 0.129. Relative model performance,
coefficients and predictions differed slightly but signifi-
cantly between the two estimation datasets.
Conclusions The resulting response mapping algorithm
can be used to predict EQ-5D utilities and responses from
OKS responses. Response mapping appears to perform
particularly well in large datasets.
Keywords Mapping  Cross-walking  Health-related
quality of life  Joint replacement  Health state preference
values
Abbreviations
EOC Elective Orthopaedics Centre [dataset]
GLM Generalized linear model
HRQoL Health-related quality of life
KAT Knee Arthroplasty Trial
MAE Mean absolute error
MSE Mean squared error
OLS Ordinary least squares
OKS Oxford Knee Score
PROMs Patient Reported Outcome Measures [initiative]
QALY Quality-adjusted life-year
Introduction
Although condition-specific health-related quality-of-life
(HRQoL) measures may be more sensitive and [1, 2]
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sufficient to assess efficacy, comparing incremental cost-
effectiveness between conditions requires generic mea-
sures, such as the EQ-5D [3–5], that give health state
preferences or utilities [1, 2]. Utilities are needed for cal-
culation of quality-adjusted life-years (QALYs) and are
scaled such that one equals perfect health, zero indicates
death and negative values represent health states worse
than death.
EQ-5D, the most widely used utility scale [6], includes
five questions on mobility, self-care, pain, usual activities
and anxiety/depression, each with three response levels [3–
5]. Utility valuations for all 243 EQ-5D health states are
based on time-trade-off valuations by 3,395 members of
the UK general public [3, 4]. Alternative tariffs have been
developed for other countries [7].
There is growing interest in algorithms that map one
HRQoL measure onto another, thereby enabling estima-
tion of QALYs from trials that include condition-specific
measures but not utility instruments [8–10]. Most map-
ping studies use regression methods to directly predict
utilities from responses or scores on condition-specific
measures [8, 9]. However, response mapping models
predicting patients’ responses to a multiattribute utility
measure provide an alternative approach [9, 11–15].
Response mapping may provide better utility predictions
as well as giving richer insights into the relationship
between the two instruments, predicting the domains most
affected by disease or treatment and calculating utilities
for any tariff [11].
The Oxford Knee Score (OKS) is a widely used HRQoL
measure that was developed and validated for the assess-
ment of outcomes following knee replacement in compar-
ative trials and cohort studies [16–18]. OKS is also
increasingly used to assess eligibility for primary [19] or
revision surgery [20], although it was not designed or
validated for this purpose. It is also administered routinely
to assess the performance of hospitals or surgeons in the
UK and New Zealand Patient Reported Outcome Measures
(PROMs) initiatives [21–24]. OKS includes 12 questions
on knee symptoms and function, each with five levels.
Scores on each question, which range from 4 (no problems)
to 0 (severe problems), are summed without weighting to
produce total scores ranging from 0 to 48 [18].
Since its development in 1998, OKS has been used in
many large trials and cohort studies assessing the long-term
durability of knee components that did not include utility
measures [17]. A mapping algorithm predicting utilities
from OKS would enable long-term data from these studies
to inform cost-utility analyses.
This study estimates mapping models to predict utilities
and/or responses to the three-level EQ-5D questionnaire
based on responses and scores on the OKS. We also
compare the performance of different mapping models and





Data from the Knee Arthroplasty Trial (KAT) and the UK
PROMs initiative were combined to provide a large,
diverse sample of knee replacement patients on which to
develop a robust mapping algorithm and to test whether
mapping models are sensitive to the dataset used. Fol-
lowing best practice [10] and to avoid over-fitting during
model selection, 25 % of patients were allocated to the
internal validation sample using computer-generated ran-
dom numbers. All questionnaires from these patients were
excluded from estimation models and were instead used to
assess the prediction accuracy of each model and select the
final model specification. The estimation sample and
internal validation sample were then combined to estimate
the final model, which was externally validated on a third
dataset.
KAT comprised a randomized trial comparing different
types of knee prosthesis, in which 2,352 patients underwent
total knee replacement in the UK between 1999 and 2003.
Patients completed OKS and EQ-5D pre-operatively, three
and 12 months after knee replacement and annually
thereafter for 8–11 years to date. All questionnaires
received by 4 May 2011 that had complete responses to
OKS and EQ-5D were included in mapping analyses,
giving an estimation dataset of 12,961 questionnaires from
1,690 patients.
Within PROMs, all patients undergoing knee replace-
ment in England are sent OKS and EQ-5D questionnaires
pre-operatively and 6 months afterwards [22, 23]. We
analyzed PROMs data on admissions for knee replacement
up to 31 December 2010 that included 162,066 question-
naires with complete OKS and EQ-5D data from 106,320
patients. All questionnaires with complete data on EQ-5D
and OKS were included in mapping analyses regardless of
whether pre- and post-operative data were linked. This
provided an estimation sample of 121,308 observations
from 79,523 patients.
External validation dataset
The external validity of the best mapping algorithm was
tested using a dataset from the Elective Orthopaedics
Centre (EOC) that was not made available to the authors
until after the final model was selected. This comprised a
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large observational cohort of patients undergoing hip or
knee replacement at an NHS treatment centre serving four
NHS trusts in South-West London from January 2004
onwards [25]. Patients completed EQ-5D and OKS pre-
operatively and 6, 12 and/or 24 months afterwards.
Although recruitment is ongoing, our analysis included
only patients undergoing primary or revision knee
replacement before 31 March 2009 to avoid overlap with
PROMs. After excluding patients with incomplete data on
OKS and/or EQ-5D, this external validation dataset
included 10,002 observations from 4,505 patients.
Statistical methods
Model estimation
We first estimated direct utility mapping models by
regressing responses to individual OKS questions directly
onto EQ-5D utility using four functional forms:
• Ordinary least squares (OLS) regression.
• Generalized linear models (GLM) with log link or
gamma family predicting EQ-5D disutility (where
disutility = 1 - utility), which allow for the skewed
distribution of utility values and prevent prediction of
utilities [1.
• Fractional logistic models, which constrain predictions
to lie within the range determined by the EQ-5D tariff
(1 to -0.594 [4]). These were implemented by using
GLM with binomial family and logit link to predict
utility0–1, where utility0–1 = (utility ? 0.594)/1.594.
Two-part models were used to allow for the 9.6 %
(17,184/179,482) of observations reporting perfect health
(utility of one) on EQ-5D. For such models, the first part
comprised a logistic regression model estimated on the
entire estimation sample to predict which patients had
perfect health, while the second part comprised an OLS
model predicting EQ-5D utilities for those patients with
utility \1.
We also developed and evaluated three-part models
since 45.9 % (48,318/105,235) of pre-operative question-
naires indicated severe problems on C1 EQ-5D domain and
therefore had substantially lower utility due to the N3 term
in the EQ-5D tariff [4]. The first part of this model com-
prised multinomial logistic regression (mlogit) to predict
whether patients had perfect health, severe problems on C1
EQ-5D domain or only mild–moderate problems. The
second and third parts comprised OLS models to predict
EQ-5D utility for the subset of patients with severe prob-
lems on C1 EQ-5D domain and for those with only mild–
moderate problems, respectively.
We also used response mapping to predict the response
level that patients selected for each of the five EQ-5D
domains. These were estimated by fitting a separate mlogit
or ordinal logistic regression (ologit) model for each EQ-
5D domain, as described previously [11].
The explanatory variables for all models comprised 48
dummy variables indicating whether or not patients had a
particular response level on each OKS question; response
level 4 (no problems) comprised the comparison group.
However, all models were also evaluated using two alter-
native sets of explanatory variables: 12 OKS question
scores (rankings from 0 to 4); and total OKS (measured
from 0 to 48 [18] based on unweighted summation of
question scores). We also investigated whether adding sex
into the best performing model improved prediction accu-
racy; to ensure that the mapping algorithm can be applied
to all datasets, no other patient characteristics were added.
All models were estimated in Stata version 11 (Stata-
Corp, College Station, TX). For all models, the cluster
option within Stata was used to adjust standard errors to
allow for clustering of observations within patients. Stan-
dard errors from two-part, three-part and response mapping
models were also adjusted using seemingly unrelated
regression to allow for correlations between EQ-5D
domains [26].
Assessing model performance
Predicted EQ-5D utilities were estimated for each mapping
model. Predictions from direct mapping models were esti-
mated using the predict post-estimation command, with
direct back-transformations applied to predictions from GLM
and fractional logit models. For OLS models, any utilities
predicted to be[1 were set to one. For two-part models, the
expected utility for each patient was estimated as
Utility = PrðUtility ¼ 1Þ þ ð1  PrðUtility ¼ 1ÞÞU ð1Þ
where U equals the predicted utility conditional on
imperfect health and Pr(Utility = 1) the predicted proba-
bility of having perfect health.
Similarly, for three-part models,
Utility ¼ PrðUtility ¼ 1Þ þ PrðN3ÞUN3
þ ð1  PrðUtility ¼ 1Þ  PrðN3ÞÞUmildmoderate
ð2Þ
where Pr(N3) indicates the probability of having severe
problems on C1 domain, UN3 the predicted utility condi-
tional on this and Umild-moderate the predicted utility con-
ditional on mild–moderate problems.
For response mapping models, the highest probability
method (assuming that patients have the EQ-5D response
level for which the predicted probability from multinomial/
ordinal logistic regression is highest) has been shown to
give biased predictions, and, in particular, underestimates
Qual Life Res (2013) 22:683–694 685
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the probability that patients will have severe problems [11,
14]. Instead, we generated predictions from response
mapping models using the expected value method [14].
This is equivalent to the Monte Carlo method [11] given a
large number of repeated Monte Carlo draws [14].
Models were selected based on the mean squared
error (MSE) in the combined internal validation sample,
where MSE equals the mean of squared differences
between observed and predicted EQ-5D utility. Mean
absolute error (MAE, the mean of absolute differences
between observed and predicted EQ-5D utility) was also
calculated.
Two further analyses assessed whether different datasets
produced significantly different mapping models. Firstly,
mapping models were estimated on the combined estima-
tion dataset with a full set of interaction terms capturing the
effect of data coming from KAT rather than PROMs on the
coefficients for each OKS response. Secondly, each map-
ping model was re-estimated separately using each dataset




Across both KAT and PROMs, patients had poor pre-
operative HRQoL, with mean OKS of 18.6 (SD: 7.9; range:
0, 48; Table 1) and mean utility of 0.39 (SD: 0.32, range:
-0.594, 1), which is lower than those reported for many
forms of cancer or cardiovascular disease [27]. In partic-
ular, 87.5 % (92,124/105,235) of patients had problems
with mobility, usual activities and pain pre-operatively.
HRQoL improved substantially following knee replace-
ment to a mean OKS of 33.8 (SD: 10.2; range: 0, 48) and
mean utility of 0.70 (SD: 0.27; range: -0.594, 1). Like
some previous mapping datasets [10], post-operative
EQ-5D utilities followed a trimodal distribution (Fig. 1).
Total OKS was highly correlated with EQ-5D utility
(R2 = 0.61; p \ 0.001). All OKS items showed significant
Spearman’s rank correlations with all EQ-5D domains
(p \ 0.0001), and all OKS and EQ-5D questions loaded
strongly onto a single component explaining 40 % of the
variance in pre-operative scores and 54 % post-operatively.
Plotting mean utility against OKS question ranking sug-
gested that response levels were approximately linear with
respect to utility for all OKS items other than pain (which
showed a larger drop in utility between levels 0 and 1 than
between other levels) and washing/drying, walking, shop-
ping and going downstairs (which showed a much smaller
drop between levels 0 and 1).
Comparison of mapping model specifications
Eight mapping functions were evaluated using the com-
bined estimation dataset (Table 2), which comprised
134,269 observations of 81,213 patients drawn from both
the KAT and PROMs datasets.
Across all functional forms, models using dummies
indicating responses to OKS questions as explanatory
variables produced better predictions than those using
question or total scores (data not shown). However, all
models using OKS responses as explanatory variables
showed some logical inconsistencies in coefficient values
that contradicted the implicit ordering whereby OKS
response level 4 is unambiguously best, followed by level
3, 2, 1 and then 0.
Based on MSE, the primary measure of prediction accu-
racy, a response mapping algorithm using mlogit gave best
predictions (MSE: 0.0356; Table 2), followed by the three-
part model (MSE: 0.0358). However, the three-part model had
lower MAE than mlogit (0.1338 vs 0.1341). The ologit
response mapping (MSE: 0.0359), two-part model (MSE:
0.0360) and OLS (MSE: 0.0363) also performed reasonably
well. However, fractional logit and GLM models gave
relatively poor predictions (MSE: 0.0367–0.0397) and
systematically underestimated utilities by an average of
0.00063–0.0025. The mlogit model also overestimated utili-
ties for those with utility\0.5 by less than any other model
(mean residual: 0.160, vs 0.162–0.170) but underestimated
utilities for patients with utility C0.5 by a larger amount than
any model other than ologit or GLM with gamma link (mean
residual: -0.078, vs -0.075 to -0.076).
Impact of dataset on results
The relative performance of different model specifications
differed between datasets (Fig. 2). When models were
estimated using KAT data, a two-part model performed
best in the KAT internal validation sample (MSE =
0.0331). However, mlogit performed best (MSE = 0.0356)
among the models estimated on PROMs. Models estimated
using the PROMs dataset gave more accurate predictions
than those fitted on KAT for both pre-operative and post-
operative observations. Models fitted on the PROMs or
combined datasets also had up to 20 % fewer OKS items
with counter-intuitive signs or rankings and converged
more easily than those estimated using KAT.
We then fitted the best five models to the combined
dataset with a full set of interaction terms capturing the
effect of dataset on coefficient values. This suggested that
15–27 % of coefficients differed significantly between
datasets (p \ 0.05). Notably, all coefficients for the work
OKS item were significantly higher and those for washing/
drying were significantly lower for KAT than PROMs
686 Qual Life Res (2013) 22:683–694
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Table 1 Health-related quality-of-life scores for validation and estimation datasets
















Proportion of patients at level 2 or level 3 on EQ-5D items
Mobility
L2: 96.2 % 57.2 % 93.4 % 52.6 % 76.9 % 77.2 % 64.2 %
L3: 0.5 % 0.1 % 0.4 % 0.1 % 0.3 % 0.3 % 0.43 %
Self-care
L2: 29.7 % 24.3 % 32.8 % 21.0 % 28.1 % 28.3 % 26.7 %
L3: 0.2 % 0.5 % 1.0 % 0.5 % 0.8 % 0.8 % 1.2 %
Usual activities
L2: 76.9 % 56.1 % 76.2 % 52.8 % 66.8 % 66.8 % 59.4 %
L3: 8.9 % 5.2 % 15.2 % 5.4 % 11.0 % 11.1 % 8.2 %
Pain and discomfort
L2: 54.9 % 58.8 % 58.4 % 61.3 % 59.4 % 59.0 % 58.1 %
L3: 44.2 % 7.4 % 40.6 % 6.3 % 26.3 % 27.1 % 16.6 %
Anxiety/depression
L2: 38.3 % 24.6 % 35.2 % 21.3 % 29.7 % 30.1 % 28.5 %
L3: 2.9 % 1.7 % 4.6 % 2.6 % 3.6 % 3.8 % 3.6 %
Mean (SD) HRQoL score
EQ-5D utility 0.38 (0.31) 0.69 (0.27) 0.39 (0.32) 0.7 (0.27) 0.51 (0.34) 0.52 (0.34) 0.61 (0.32)
Total OKS 18.01 (7.57) 33.79 (10.43) 18.59 (7.95) 33.79 (10.2) 24.76 (11.67) 24.86 (11.68) 29.11 (11.70)
Usual level of
pain




2.76 (1.02) 3.35 (0.88) 2.79 (1.03) 3.43 (0.84) 3.04 (1.01) 3.05 (1.01) 3.13 (0.98)
Trouble with
transport








1.59 (0.85) 3.01 (0.97) 1.64 (0.82) 2.94 (0.94) 2.17 (1.09) 2.18 (1.09) 2.6 (1.10)
Limping 0.81 (1.02) 2.98 (1.21) 0.88 (0.99) 2.88 (1.2) 1.7 (1.47) 1.71 (1.47) 2.29 (1.47)
Difficulty
kneeling
0.70 (0.87) 1.23 (1.31) 0.79 (0.89) 1.4 (1.33) 1.02 (1.13) 1.02 (1.13) 1.40 (1.24)




1.54 (0.88) 2.99 (1.05) 1.39 (0.88) 2.87 (1.07) 2 (1.21) 2.01 (1.21) 2.41 (1.23)
Sense of knee
instability









1.57 (0.91) 2.64 (1.16) 1.71 (0.92) 2.85 (1.08) 2.15 (1.13) 2.16 (1.13) 2.48 (1.11)
Patient observations with missing data on one or more questions in EQ-5D or OKS were omitted
HRQoL health-related quality of life, KAT Knee Arthroplasty Trial, L2 Level 2 on EQ-5D, L3 Level 3 on EQ-5D, OKS Oxford Knee Score, PROMs Patient
Reported Outcome Measures [dataset], SD standard deviation, EOC Elective Orthopaedics Centre [dataset]
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unless questionnaires more than 6 months post-operation
were excluded, probably due to the effect of ageing and
retirement during the longer KAT follow-up.
However, cross-validation prediction accuracy was
good, with a two-part model fitted using KAT data having
an MSE of 0.0361 in the PROMs validation sample and the
mlogit PROMs model having an MSE of 0.0338 in KAT.
The predictions from models estimated on the two datasets
were also very similar: the mean absolute difference in
predictions between the two-part model estimated on
KAT data and the mlogit PROMs model was 0.031
(p \ 0.0001), while the difference in predicted change
from baseline at 3–6 months was 0.0042 (p = 0.003). Both
models accurately predicted the mean utility in the other
dataset: the mlogit PROMs model predicted the mean
utility in KAT to be 0.665, vs an observed value of 0.654,
while the two-part KAT model predicted the mean PROMs
utility to be 0.496 vs an observed value of 0.503. Coeffi-
cient values and choice of model also differed between pre-
and post-operative observations, although models of
pre-operative utilities predicted post-operative utilities well





















-.5 0 .5 1
Observed EQ-5D utility
a b
Fig. 1 Distribution of a pre-operative and b post-operative EQ-5D utilities
Table 2 Comparison of performance across models investigated using combined dataset









Direct utility mapping models
OLS EQ-5D utility 0.0363 0.0362 0.1398 0.1399
GLM (gamma family; identity link) 1 - EQ-5D utility 0.0397 0.0393 0.1467 0.1466
GLM (Gaussian family; log link) 1 - EQ-5D utility 0.0370 0.0368 0.1415 0.1415
Fractional logit (EQ-5D utility ? 0.594)/1.594 0.0367 0.0365 0.1403 0.1403
2-part models: 0.0360 0.0359 0.1384 0.1384
Part 1: logistic regression predicting perfect healtha
Part 2: OLS predicting utility given imperfect health
3-part models: 0.0358 0.0357 0.1338 0.1341
Part 1: mlogit on perfect health, N3 or neitherb
Part 2: OLS on utility for pts with neither N3 nor perfect health
Part 3: OLS on utility for N3 pts
Response mapping models
ologit response mapping EQ-5D responses for each domain in turn 0.0359 0.0358 0.1361 0.1363
mlogit response mapping EQ-5D responses for each domain in turn 0.0356 0.0354 0.1341 0.1343
GLM generalized linear model, MAE mean absolute error, MSE mean squared error, OKS Oxford Knee Score, OLS ordinary least squares
a Problems with perfect prediction arose when all response levels for washing/drying question were included; results are shown for a model
merging levels 0 and 1 for this question
b Problems with non-symmetric or highly singular variance matrix arose when all response levels for washing/drying and work questions were
included; results are shown for a model merging levels 0 and 1 for these questions
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Performance of best model
Although the relationship between OKS and EQ-5D dif-
fered significantly between datasets and following knee
replacement, the magnitude of such differences was very
small. Furthermore, mapping models fitted on a heteroge-
neous population including both baseline and post-treat-
ment observations and those from trials and routine clinical
practice are likely to be useful for most practical applica-
tions. The mlogit response mapping model fitted on the
combined estimation dataset was therefore selected as the
best model since it gave the lowest MSE overall for both
pre- and post-operative observations.
Adding patient sex into this model reduced MSE by only
0.0000073, to 0.03554. The final model (Table 3; Appendix 1:
Electronic supplementary material) therefore included only
OKS responses and was fitted on the entire KAT and PROMs
dataset (including the internal validation sample).
The final model accurately predicted EQ-5D utility in
the combined KAT/PROMs sample (MSE: 0.0355; MAE:
0.134) and the external EOC sample (MSE: 0.0330; MAE:
0.129). Within EOC, 18 % of predictions were within 0.05
and 42 % within 0.10 of the observed utility value; pre-
dicted and observed utilities were strongly correlated (R2:
0.69; Fig. 3a). The predicted proportions of patients with
different response levels on each domain were very similar,
but were significantly different from the observed propor-
tions (p \ 0.0001, based on chi-squared test in Microsoft
Excel 2003): for example, the model predicted that 26 %
of EOC questionnaires indicated some anxiety and
depression, compared with the 28.5 % (2,848/10,002)
observed. The model also accurately predicted mean utility
(observed: 0.607; predicted: 0.597) in EOC. Like most
mapping models [10], ceiling and floor effects produced
heteroskedastic residuals, causing our model to slightly
underestimate utilities for patients with high EQ-5D utility
and overestimate utility for patients with low utility
(Fig. 3b). Predicted utilities also had a smaller range
(-0.29 to 0.95 vs -0.594 to 1) and standard deviation
(0.26 vs 0.32) than observed values.
For all models, prediction accuracy was better for post-
operative observations (Fig. 2) and observations with high
utility (Fig. 3d) and markedly worse for patients with OKS
between 11 and 20 than for those with better or worse knee
function (Fig. 3c). Within the KAT baseline sample, pre-
dictions were also less accurate (MSE: 0.043) for those
with poor pre-operative general health (ASA grade 3–4)
and those with arthritis in other joints. The final model also
accurately predicted change in utility following knee
replacement (MSE: 0.0656; MAE: 0.192).
Discussion
We have developed a mapping algorithm that accurately
predicts EQ-5D utility based on OKS responses; model
performance was similar to previous mapping models,
which have obtained MAEs between 0.0011 and 0.19 [8].
The mapping model shown in Table 3 can be used to
predict responses to the EQ-5D questionnaire and EQ-5D
utilities in situations where only OKS has been adminis-
tered. In particular, this will facilitate cost-utility analyses
of the numerous trials and registries that used OKS but no
utility measure. Excel and Stata code developed to estimate
predictions are available at http://www.herc.ox.ac.uk/down
loads, and methods to estimate standard errors around pre-
dictions from the variance–covariance matrices of response
mapping models (Appendix 1) are under development.








































Fig. 2 Mean squared error
(MSE) for models fitted on each
dataset. Models were tested in
their respective internal
validation samples: for
example, the performance of
models estimated using KAT
was tested on 25 % of the KAT
sample. *Levels 0/1 (or levels
3/4) were merged for one or
more OKS item in logistic
regression models as problems
with perfect prediction or non-
symmetric/highly singular
variance matrices arose with the
first-part model when all
response levels were included
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responses, although a simpler model for secondary data is
available at http://www.herc.ox.ac.uk/downloads. How-
ever, mapping is no substitute for including a utility mea-
sure in future studies and does not overcome the limitations
of either instrument [10].
In addition to producing more accurate predictions in
this study, response mapping models naturally deal with
non-Gaussian utility distributions and mirror the way util-
ities are calculated. Furthermore, while direct mapping
models must be developed for specific tariffs, response
mapping algorithms can be applied to any three-level EQ-
5D tariff available now or in the future [11]. Although
prediction accuracy varied with tariff, our algorithm gave
accurate predictions of utilities in the external valida-
tion sample using the EQ-5D tariffs for Spain, Germany,
Netherlands, Denmark, Japan, Zimbabwe and USA (MSE B
0.055). Response mapping also gives richer insights into the
relationship between the two instruments, for instance pre-
dicting the proportion of patients with different response
levels on each domain. However, such models appear to
perform much better when estimated on very large datasets.
The three-part model specification we developed to deal
with the N3 term in the UK EQ-5D tariff also performed
very well; this specification may be particularly useful for
other mapping applications where severe problems on EQ-
5D domains are common.
Our dataset is (to our knowledge) the largest sample
used for mapping analyses to date and covers the full range
of EQ-5D and OKS scores. In particular, our large sample
size appears to have overcome previously cited difficulties
with mapping between Oxford Hip Score and EQ-5D, such
as lack of overlap between pre- and post-operative scores
and poor prediction of anxiety and depression [28].
Although the model performed well overall, predictions
were less accurate for patients with OKS between 11 and
20, which appears to be due to uncertainty about which
54.3 % of such patients have severe problems on C1
domain, since MSE did not vary markedly with OKS when
observed and predicted utilities were recalculated without
the N3 term. The N3 term may also explain the general
finding of higher accuracy for healthier patients [8].
However, the performance of our mapping algorithm in
populations dissimilar to ours (e.g. patients with early
arthritis) or for studies using non-English language ques-
tionnaires is unknown.
Although OKS includes questions directly relating to
mobility, self-care, usual activities and pain, no OKS
questions directly ask about psychological symptoms or
strongly predict responses to the EQ-5D anxiety/depres-
sion question (mlogit pseudo-R2: 0.14 for anxiety/
depression, vs 0.36–0.55 for other domains). Nonetheless,
we found that OKS predicts anxiety/depression responses
reasonably accurately, probably as pain and poor knee
function explain much of the anxiety/depression observed
in this population. Nonetheless, any mapping algorithm
between OKS and EQ-5D is likely to perform poorly in
subgroups of patients who have psychological conditions
that unrelated to their knee problems. Our mapping
algorithm was also less accurate in patients with comor-
bidities or arthritis in other joints, probably due to OKS’
focus on knee problems.
Models using dummies indicating OKS response level
as the explanatory variable gave better predictions than
those modelling total or question scores. This demonstrates
the advantages of modelling response levels for each
question whenever the estimation dataset is large enough to
estimate coefficients reliably. Regression analyses also
indicate that some items (e.g. pain or impact on work) have
more effect on utility than others (Table 3). OKS total
score was nonetheless a strong predictor of EQ-5D, sug-
gesting that the OKS scoring system (which assigns equal
weight to all questions and assumes levels are equally
spaced given the wording of questions and response levels)
is a good measure of HRQoL.
However, coefficients for some OKS response levels
had counter-intuitive signs or rankings (Table 3): for
example, the coefficients showing the effect of being
unable to walk at all without severe pain (0.35) or being
able to walk only around the house (0.86) on having level 2
mobility were lower than the coefficient for walking
5–15 min (0.99). Such inconsistencies were less common
in mapping models fitted on the larger PROMs dataset than
on KAT, although 57 % of OKS items were inconsistent in
the final model (Table 3). Similar inconsistencies have
been observed previously [8, 11, 29]. These inconsistencies
could cause the mapping algorithm to predict that a
patient’s utility had fallen when their OKS profile was
unambiguously improved. In principle, items could be
omitted or levels merged to give a fully consistent mapping
algorithm with higher face validity: particularly as the
specific inconsistencies observed appeared to vary between
datasets, suggesting that many such inconsistencies
occurred by chance. However, we feel that it is more
appropriate to use the mapping model giving highest pre-
diction accuracy in the validation sample regardless of
inconsistencies, rather than applying ad hoc methods that
could give many different ‘‘consistent’’ algorithms. Fur-
thermore, we found that omitting/merging OKS levels
reduced prediction accuracy, suggesting that inconsisten-
cies may reflect patients’ interpretation of the questions or
genuine opposition between items.
Model choice and coefficient values were sensitive to
the dataset used to estimate mapping models. However,
while the predictions and coefficients differed significantly
between datasets, such differences are unlikely to be large
enough to affect the results of an economic evaluation:
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particularly as differences in change from baseline
were smaller than those for absolute values. Longer
post-operative follow-up in KAT may explain many of
these differences, although differences could also arise
from slight differences in methods of questionnaire
administration/wording or secular trends between operation
dates (1999–2003 for KAT and 2009–2010 for PROMs).
Other explanations, such as differing patient characteristics
or questionnaire translations, are unlikely in this case as
cohorts were similar and all questionnaires were completed
in English. Although the relationship between OKS and
EQ-5D appears to differ slightly between pre- and post-
operative observations, using different mapping algorithms
for different timepoints could bias cost-effectiveness esti-
mates. Furthermore, adding observations from trial data
with long follow-up (KAT) to those from routine data
(PROMs) is likely to increase the range of applications to
which mapping algorithms can be applied.
Nonetheless, differences between datasets highlight the
importance of external validation. Selecting models based
on performance in an internal validation dataset not used in
model estimation helps prevent over-fitting, while external
validation provides a more rigorous test of predictive
accuracy by assessing performance in a separate,
independently collected dataset that was not used for model
estimation or selection [10, 30]. Our model gave accurate
predictions in both internal and external validation data-
sets, demonstrating that it is likely to perform well in other
comparable populations.
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Fig. 3 Performance of the best model in the external validation
sample. a Scatter plot showing correlation between observed and
predicted EQ-5D utility. b Scatter plot showing correlation between
residual (predicted minus observed EQ-5D utility) and observed EQ-
5D utility. c Mean squared error by OKS. d Mean squared error by
observed EQ-5D
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